Global Liposomal Drug Delivery System Industry

2024-2030 Global Liposomal Drug Delivery System Industry Research & Trends Analysis Report

Global Liposomal Drug Delivery System Industry

2024-2030 Global Liposomal Drug Delivery System Industry Research & Trends Analysis Report


The Global Liposomal Drug Delivery System Market investigation report contains Types, Application & all logical and factual briefs about market 2024 Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Gilead, Novartis, Pfizer, Teva, Bristol-Myers Squibb, CordenPharma, others.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to latest Research, the global market for Liposomal Drug Delivery System should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Liposomal Drug Delivery System market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Liposomal Drug Delivery System market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Liposomal Doxorubicin segment holds a share about % in 2023 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Liposomal Drug Delivery System include Johnson & Johnson Services, Inc. (U.S.), Gilead Sciences Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd (Israel), Janssen Pharmaceuticals Inc. (Belgium), CELSION corporation (U.S.）, Abbott (U.S.) and Ipsen Pharma (France), etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Liposomal Drug Delivery System. Report Highlights:

(1) Global Liposomal Drug Delivery System market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Liposomal Drug Delivery System market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Liposomal Drug Delivery System market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Liposomal Drug Delivery System segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Liposomal Drug Delivery System segment by type and by application and regional segment by type and by application.

(6) Liposomal Drug Delivery System industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Liposomal Doxorubicin

Liposomal Paclitaxel

Liposomal Amphotericin B

Others

Market segment by application, can be divided into

Hospital

Specialty Clinic

Others

Market segment by players, this report covers

Johnson & Johnson Services, Inc. (U.S.)

Gilead Sciences Inc. (U.S.)

Sun Pharmaceutical Industries Ltd. (India)

Novartis AG (Switzerland)

Teva Pharmaceutical Industries Ltd (Israel)

Janssen Pharmaceuticals Inc. (Belgium)

CELSION corporation (U.S.）

Abbott (U.S.)

Ipsen Pharma (France)

Spectrum Pharmaceuticals, Inc. (U.S.)

Takeda Pharmaceutical Company Limited. (Japan)

1 Market Overview

1.1 Product Overview and Scope of Liposomal Drug Delivery System

1.2 Global Liposomal Drug Delivery System Market Size and Forecast

1.3 China Liposomal Drug Delivery System Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Liposomal Drug Delivery System Share in Global Market, 2019-2030

1.4.2 Liposomal Drug Delivery System Market Size: China VS Global, 2019-2030

1.5 Liposomal Drug Delivery System Market Dynamics

1.5.1 Liposomal Drug Delivery System Market Drivers

1.5.2 Liposomal Drug Delivery System Market Restraints

1.5.3 Liposomal Drug Delivery System Industry Trends

1.5.4 Liposomal Drug Delivery System Industry Policy

2 Global Competitive Situation by Company

2.1 Global Liposomal Drug Delivery System Revenue by Company (2019-2024)

2.2 Global Liposomal Drug Delivery System Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Liposomal Drug Delivery System Concentration Ratio

2.4 Global Liposomal Drug Delivery System Mergers & Acquisitions, Expansion Plans

2.5 Global Liposomal Drug Delivery System Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Liposomal Drug Delivery System Revenue by Company (2019-2024)

3.2 China Liposomal Drug Delivery System Liposomal Drug Delivery System Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Liposomal Drug Delivery System, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Liposomal Drug Delivery System Industry Chain

4.2 Liposomal Drug Delivery System Upstream Analysis

4.3 Liposomal Drug Delivery System Midstream Analysis

4.4 Liposomal Drug Delivery System Downstream Analysis

5 Sights by Type

5.1 Liposomal Drug Delivery System Classification

5.1.1 Liposomal Doxorubicin

5.1.2 Liposomal Paclitaxel

5.1.3 Liposomal Amphotericin B

5.1.4 Others

5.2 By Type, Global Liposomal Drug Delivery System Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Liposomal Drug Delivery System Revenue, 2019-2030

6 Sights by Application

6.1 Liposomal Drug Delivery System Segment by Application

6.1.1 Hospital

6.1.2 Specialty Clinic

6.1.3 Others

6.2 By Application, Global Liposomal Drug Delivery System Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Liposomal Drug Delivery System Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Liposomal Drug Delivery System Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Liposomal Drug Delivery System Market Size, 2019-2030

7.3 North America

7.3.1 North America Liposomal Drug Delivery System Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Liposomal Drug Delivery System Market Size Market Share

7.4 Europe

7.4.1 Europe Liposomal Drug Delivery System Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Liposomal Drug Delivery System Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Liposomal Drug Delivery System Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Liposomal Drug Delivery System Market Size Market Share

7.6 South America

7.6.1 South America Liposomal Drug Delivery System Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Liposomal Drug Delivery System Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Liposomal Drug Delivery System Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Liposomal Drug Delivery System Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Liposomal Drug Delivery System Market Size, 2019-2030

8.3.2 By Company, U.S. Liposomal Drug Delivery System Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.3.4 By Application, U.S. Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.4 Europe

8.4.1 Europe Liposomal Drug Delivery System Market Size, 2019-2030

8.4.2 By Company, Europe Liposomal Drug Delivery System Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.4.4 By Application, Europe Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.5 China

8.5.1 China Liposomal Drug Delivery System Market Size, 2019-2030

8.5.2 By Company, China Liposomal Drug Delivery System Revenue Market Share, 2019-2024

8.5.3 By Type, China Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.5.4 By Application, China Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.6 Japan

8.6.1 Japan Liposomal Drug Delivery System Market Size, 2019-2030

8.6.2 By Company, Japan Liposomal Drug Delivery System Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.6.4 By Application, Japan Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.7 South Korea

8.7.1 South Korea Liposomal Drug Delivery System Market Size, 2019-2030

8.7.2 By Company, South Korea Liposomal Drug Delivery System Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.7.4 By Application, South Korea Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Liposomal Drug Delivery System Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Liposomal Drug Delivery System Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.8.4 By Application, Southeast Asia Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.9 India

8.9.1 India Liposomal Drug Delivery System Market Size, 2019-2030

8.9.2 By Company, India Liposomal Drug Delivery System Revenue Market Share, 2019-2024

8.9.3 By Type, India Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.9.4 By Application, India Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Liposomal Drug Delivery System Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Liposomal Drug Delivery System Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

8.10.4 By Application, Middle East & Asia Liposomal Drug Delivery System Revenue Market Share, 2024 VS 2030

9 Global Manufacturers Profile

9.1 Johnson & Johnson Services, Inc. (U.S.)

9.1.1 Johnson & Johnson Services, Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position

9.1.2 Johnson & Johnson Services, Inc. (U.S.) Company Profile and Main Business

9.1.3 Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application

9.1.4 Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.1.5 Johnson & Johnson Services, Inc. (U.S.) Recent Developments

9.2 Gilead Sciences Inc. (U.S.)

9.2.1 Gilead Sciences Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position

9.2.2 Gilead Sciences Inc. (U.S.) Company Profile and Main Business

9.2.3 Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application

9.2.4 Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.2.5 Gilead Sciences Inc. (U.S.) Recent Developments

9.3 Sun Pharmaceutical Industries Ltd. (India)

9.3.1 Sun Pharmaceutical Industries Ltd. (India) Company Information, Head Office, Market Area and Industry Position

9.3.2 Sun Pharmaceutical Industries Ltd. (India) Company Profile and Main Business

9.3.3 Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Models, Specifications and Application

9.3.4 Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.3.5 Sun Pharmaceutical Industries Ltd. (India) Recent Developments

9.4 Novartis AG (Switzerland)

9.4.1 Novartis AG (Switzerland) Company Information, Head Office, Market Area and Industry Position

9.4.2 Novartis AG (Switzerland) Company Profile and Main Business

9.4.3 Novartis AG (Switzerland) Liposomal Drug Delivery System Models, Specifications and Application

9.4.4 Novartis AG (Switzerland) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.4.5 Novartis AG (Switzerland) Recent Developments

9.5 Teva Pharmaceutical Industries Ltd (Israel)

9.5.1 Teva Pharmaceutical Industries Ltd (Israel) Company Information, Head Office, Market Area and Industry Position

9.5.2 Teva Pharmaceutical Industries Ltd (Israel) Company Profile and Main Business

9.5.3 Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Models, Specifications and Application

9.5.4 Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.5.5 Teva Pharmaceutical Industries Ltd (Israel) Recent Developments

9.6 Janssen Pharmaceuticals Inc. (Belgium)

9.6.1 Janssen Pharmaceuticals Inc. (Belgium) Company Information, Head Office, Market Area and Industry Position

9.6.2 Janssen Pharmaceuticals Inc. (Belgium) Company Profile and Main Business

9.6.3 Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Models, Specifications and Application

9.6.4 Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.6.5 Janssen Pharmaceuticals Inc. (Belgium) Recent Developments

9.7 CELSION corporation (U.S.）

9.7.1 CELSION corporation (U.S.） Company Information, Head Office, Market Area and Industry Position

9.7.2 CELSION corporation (U.S.） Company Profile and Main Business

9.7.3 CELSION corporation (U.S.） Liposomal Drug Delivery System Models, Specifications and Application

9.7.4 CELSION corporation (U.S.） Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.7.5 CELSION corporation (U.S.） Recent Developments

9.8 Abbott (U.S.)

9.8.1 Abbott (U.S.) Company Information, Head Office, Market Area and Industry Position

9.8.2 Abbott (U.S.) Company Profile and Main Business

9.8.3 Abbott (U.S.) Liposomal Drug Delivery System Models, Specifications and Application

9.8.4 Abbott (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.8.5 Abbott (U.S.) Recent Developments

9.9 Ipsen Pharma (France)

9.9.1 Ipsen Pharma (France) Company Information, Head Office, Market Area and Industry Position

9.9.2 Ipsen Pharma (France) Company Profile and Main Business

9.9.3 Ipsen Pharma (France) Liposomal Drug Delivery System Models, Specifications and Application

9.9.4 Ipsen Pharma (France) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.9.5 Ipsen Pharma (France) Recent Developments

9.10 Spectrum Pharmaceuticals, Inc. (U.S.)

9.10.1 Spectrum Pharmaceuticals, Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position

9.10.2 Spectrum Pharmaceuticals, Inc. (U.S.) Company Profile and Main Business

9.10.3 Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application

9.10.4 Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.10.5 Spectrum Pharmaceuticals, Inc. (U.S.) Recent Developments

9.11 Takeda Pharmaceutical Company Limited. (Japan)

9.11.1 Takeda Pharmaceutical Company Limited. (Japan) Company Information, Head Office, Market Area and Industry Position

9.11.2 Takeda Pharmaceutical Company Limited. (Japan) Company Profile and Main Business

9.11.3 Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Models, Specifications and Application

9.11.4 Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024

9.11.5 Takeda Pharmaceutical Company Limited. (Japan) Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Liposomal Drug Delivery System Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Liposomal Drug Delivery System Market trending toward high growth trajectories?
A dynamic process in the Liposomal Drug Delivery System Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Gilead, Novartis, Pfizer, Teva, Bristol-Myers Squibb, CordenPharma, others..
What is the Liposomal Drug Delivery System Market really preparing for?
Companies in the Liposomal Drug Delivery System Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
What are the major applications for Liposomal Drug Delivery System ?
Liposomal Drug Delivery System has a wide range of applications, including and others.
What is the forecasted growth rate of the Liposomal Drug Delivery System Market?
The Liposomal Drug Delivery System Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
In the current situation, what value does the Liposomal Drug Delivery System Market have?
The value of the Liposomal Drug Delivery System Market is estimated to be USD XXX million.
How is the Liposomal Drug Delivery System Market's changing dynamics captured?
The Liposomal Drug Delivery System analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.